Published in Am J Pathol on October 01, 1996
The genetic basis of kidney cancer: a metabolic disease. Nat Rev Urol (2010) 5.04
Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors. Am J Pathol (1997) 1.63
State of the science: an update on renal cell carcinoma. Mol Cancer Res (2012) 1.58
Tuberous sclerosis complex renal disease. Nephron Exp Nephrol (2010) 1.29
Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development. Proc Natl Acad Sci U S A (1998) 1.28
A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation. Am J Pathol (2001) 1.27
Molecular aspects of renal cell carcinoma: a review. Am J Cancer Res (2010) 1.25
The pathogenesis and imaging of the tuberous sclerosis complex. Pediatr Radiol (2008) 1.20
Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond. Pediatr Nephrol (2005) 1.15
Analysis of the TSC1 and TSC2 genes in sporadic renal cell carcinomas. Br J Cancer (2001) 1.11
The metabolic basis of kidney cancer. Semin Cancer Biol (2012) 1.09
Renal cell carcinoma in tuberous sclerosis complex. Am J Surg Pathol (2014) 1.08
MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism. Proc Natl Acad Sci U S A (2015) 1.07
The TRC8 ubiquitin ligase is sterol regulated and interacts with lipid and protein biosynthetic pathways. Mol Cancer Res (2010) 1.07
Targeted therapeutic strategies for the management of renal cell carcinoma. Curr Opin Oncol (2012) 1.00
Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma: epidermal growth factor is the required growth factor. Am J Pathol (2005) 1.00
Complete inactivation of the TSC2 gene leads to formation of hamartomas. Am J Hum Genet (1999) 0.95
Survivin expression in tuberous sclerosis complex cells. Mol Med (2007) 0.88
A shower of second hit events as the cause of multifocal renal cell carcinoma in tuberous sclerosis complex. Hum Mol Genet (2014) 0.87
Clinical and molecular insights into tuberous sclerosis complex renal disease. Pediatr Nephrol (2010) 0.87
Renal involvement in tuberous sclerosis complex and von Hippel-Lindau disease: shared disease mechanisms? Nat Clin Pract Nephrol (2009) 0.84
13-year-old tuberous sclerosis patient with renal cell carcinoma associated with multiple renal angiomyolipomas developing multifocal micronodular pneumocyte hyperplasia. BMC Clin Pathol (2013) 0.83
Two different renal cell carcinomas and multiple angiomyolipomas in a patient with tuberous sclerosis. Korean J Urol (2010) 0.81
Tuberous Sclerosis Complex: new criteria for diagnostic work-up and management. Wien Klin Wochenschr (2015) 0.81
cAMP-dependent cytosolic mislocalization of p27(kip)-cyclin D1 during quinol-thioether-induced tuberous sclerosis renal cell carcinoma. Toxicol Sci (2011) 0.81
Novel mechanism of regulation of fibrosis in kidney tumor with tuberous sclerosis. Mol Cancer (2013) 0.80
Multiple roles and therapeutic implications of Akt signaling in cancer. Onco Targets Ther (2009) 0.80
Giant abdominopelvic epithelioid angiomyolipoma associated with tuberous sclerosis: report of a case. Surg Today (1999) 0.79
Molecular characterization of preneoplastic lesions provides insight on the development of renal tumors. Am J Pathol (2009) 0.78
Tuberin-deficiency downregulates N-cadherin and upregulates vimentin in kidney tumor of TSC patients. Oncotarget (2014) 0.77
Bilateral renal cell carcinoma in a paediatric patient with tuberous sclerosis complex. BMJ Case Rep (2013) 0.75
Rheb may complex with RASSF1A to coordinate Hippo and TOR signaling. Oncotarget (2016) 0.75
Hereditary Renal Tumor Syndromes: Update on Diagnosis and Management. Semin Ultrasound CT MR (2016) 0.75
Metabolic reprogramming in clear cell renal cell carcinoma. Nat Rev Nephrol (2017) 0.75
A Four-Year Follow-up Study of Renal Epithelioid Angiomyolipoma: A Multi-Center Experience and Literature Review. Sci Rep (2015) 0.75
Bilateral synchronous occurrence of three different histological types of renal tumor: a case report. J Med Case Rep (2009) 0.75
Suppression of tumor suppressor Tsc2 and DNA repair glycosylase Nth1 during spontaneous liver tumorigenesis in Long-Evans Cinnamon rats. Mol Cell Biochem (2009) 0.75
New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complex. J Pathol (2016) 0.75
Nuclear Pedigree Criteria for the Identification of Individuals Suspected to be at Risk of an Inherited Predisposition to Renal Cancer. Hered Cancer Clin Pract (2005) 0.75
Mosaic Disorders of the PI3K/PTEN/AKT/TSC/mTORC1 Signaling Pathway. Dermatol Clin (2017) 0.75
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A (1971) 31.05
The 1993-94 Généthon human genetic linkage map. Nat Genet (1994) 17.64
A second-generation linkage map of the human genome. Nature (1992) 16.32
Construction of a GT polymorphism map of human 9q. Genomics (1992) 8.92
Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res (1994) 3.62
Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat Genet (1994) 2.93
Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma. Hum Mol Genet (1994) 2.65
Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. Proc Natl Acad Sci U S A (1994) 2.38
A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nat Genet (1995) 2.25
Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosomes Cancer (1995) 2.20
Sarcomas and sarcomatoid and mixed malignant tumors of the kidney in adults. 3. Cancer (1968) 1.95
The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor. Hum Mol Genet (1994) 1.81
9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene. Hum Mol Genet (1994) 1.63
Familial renal adenomas in Wistar rats; a preliminary report. Acta Pathol Microbiol Scand (1954) 1.46
Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma. Cancer Res (1991) 1.28
Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas. Cancer Res (1989) 1.28
Report and abstracts of the Third International Workshop on Chromosome 9. Cambridge, United Kingdom, 9-11 April, 1994. Ann Hum Genet (1994) 1.23
A PCR-based genetic linkage map of human chromosome 16. Genomics (1994) 1.22
Tuberous sclerosis: unusual associations in four cases. J Clin Pathol (1984) 1.21
Report and abstracts of the Fourth International Workshop on Human Chromosome 3 Mapping. Cytogenet Cell Genet (1994) 1.15
A high-resolution linkage map of human 9q34.1. Genomics (1993) 1.13
Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes. Proc Natl Acad Sci U S A (1995) 1.12
Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas. Cancer Res (1995) 1.10
Anti-melanoma monoclonal antibody HMB45 identifies an oncofetal glycoconjugate associated with immature melanosomes. J Histochem Cytochem (1992) 1.08
Dinucleotide repeat polymorphism at the IFNA locus (9p22). Hum Mol Genet (1992) 1.07
Malignant renal tumors in tuberous sclerosis. Urology (1991) 1.04
Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22. Br J Cancer (1994) 1.04
A 5.4-Mb continuous pulsed-field gel electrophoresis map of human 9q34.1 between ABL and D9S114, including the tuberous sclerosis (TSC1) region. Genomics (1995) 0.90
Renal cell carcinoma and angiomyolipoma in tuberous sclerosis: case report. J Urol (1986) 0.86
Tuberous sclerosis with angiomyolipoma and metastasized hypernephroma. Urology (1986) 0.84
[Tuberculous myositis of atypical development and paratuberculous polymyositis]. Lyon Med (1960) 0.78
Construction of a GT polymorphism map of human 9q. Genomics (1992) 8.92
Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science (1997) 6.10
Nonmuscle actin-binding proteins. Annu Rev Cell Biol (1985) 5.46
Actin-binding protein requirement for cortical stability and efficient locomotion. Science (1992) 4.66
Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci U S A (2000) 4.30
Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science (1997) 4.19
Human endothelial actin-binding protein (ABP-280, nonmuscle filamin): a molecular leaf spring. J Cell Biol (1990) 3.76
Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain. Nature (1986) 3.50
Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet (2000) 3.44
Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J Clin Invest (1999) 3.38
Apparent renal cell carcinomas in tuberous sclerosis are heterogeneous: the identification of malignant epithelioid angiomyolipoma. Am J Surg Pathol (1998) 3.31
Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin. Cell (1995) 3.08
Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am J Respir Crit Care Med (2001) 2.94
Actin-binding proteins. Curr Opin Cell Biol (1991) 2.83
Schwannomatosis: a clinical and pathologic study. Neurology (1996) 2.82
Molecular genetic advances in tuberous sclerosis. Hum Genet (2000) 2.72
Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet (1996) 2.67
Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor. Oncogene (2010) 2.53
CT imaging in adults with neurofibromatosis-1: frequent asymptomatic plexiform lesions. Neurology (1998) 2.32
Enhanced motility in NIH 3T3 fibroblasts that overexpress gelsolin. Science (1991) 2.26
Gelsolin is a downstream effector of rac for fibroblast motility. EMBO J (1998) 2.23
Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosomes Cancer (1995) 2.20
Cdc42 is required for PIP(2)-induced actin polymerization and early development but not for cell viability. Curr Biol (2000) 2.19
The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis. Oncogene (2009) 2.14
Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis. Am J Hum Genet (1998) 2.13
Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Res (1998) 2.04
Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet (2005) 2.00
Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis. J Clin Invest (1997) 2.00
Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis. Am J Hum Genet (1997) 1.96
Dystonia gene in Ashkenazi Jewish population is located on chromosome 9q32-34. Ann Neurol (1990) 1.89
Structure and biosynthesis of cytoplasmic and secreted variants of gelsolin. J Biol Chem (1984) 1.87
Coordinated regulation of platelet actin filament barbed ends by gelsolin and capping protein. J Cell Biol (1996) 1.85
Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet (1992) 1.84
Suppression of tumorigenicity in simian virus 40-transformed 3T3 cells transfected with alpha-actinin cDNA. Proc Natl Acad Sci U S A (1993) 1.69
Profilin I is essential for cell survival and cell division in early mouse development. Proc Natl Acad Sci U S A (2001) 1.68
EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-associated PLCgamma signaling pathway. J Cell Sci (1998) 1.68
Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex. Cancer (1998) 1.65
Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors. Am J Pathol (1997) 1.63
Bronchioloalveolar carcinoma of the lung: recurrences and survival in patients with stage I disease. J Thorac Cardiovasc Surg (2001) 1.60
Human gene for torsion dystonia located on chromosome 9q32-q34. Neuron (1989) 1.51
Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis. Chest (2000) 1.48
Strong allelic association between the torsion dystonia gene (DYT1) andloci on chromosome 9q34 in Ashkenazi Jews. Am J Hum Genet (1992) 1.46
Qualitative and quantitative effects of APOE genetic variation on plasma C-reactive protein, LDL-cholesterol, and apoE protein. Genes Immun (2006) 1.44
Local protective effects of nerve growth factor-secreting fibroblasts against excitotoxic lesions in the rat striatum. J Neurosurg (1993) 1.44
Isolation and properties of two actin-binding domains in gelsolin. J Biol Chem (1985) 1.41
Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1. Am J Med Genet (1999) 1.40
Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions. Am J Hum Genet (2001) 1.39
Delayed retraction of filopodia in gelsolin null mice. J Cell Biol (1997) 1.39
Neuroprotective effects of gelsolin during murine stroke. J Clin Invest (1999) 1.38
The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis. Am J Respir Crit Care Med (2001) 1.35
Association of profilin with filament-free regions of human leukocyte and platelet membranes and reversible membrane binding during platelet activation. J Cell Biol (1989) 1.32
Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis. Am J Respir Crit Care Med (2001) 1.31
A 37-marker PCR-based genetic linkage map of human chromosome 9: observations on mutations and positive interference. Genomics (1995) 1.25
Mosaicism in tuberous sclerosis as a potential cause of the failure of molecular diagnosis. N Engl J Med (1999) 1.24
Loss of the Birt-Hogg-Dubé tumor suppressor results in apoptotic resistance due to aberrant TGFβ-mediated transcription. Oncogene (2011) 1.23
Do NF1 gene deletions result in a characteristic phenotype? Am J Med Genet (1997) 1.23
Report and abstracts of the Third International Workshop on Chromosome 9. Cambridge, United Kingdom, 9-11 April, 1994. Ann Hum Genet (1994) 1.23
Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. New Biol (1991) 1.22
Renal angiomyolipomas, cysts, and cancer in tuberous sclerosis complex. Semin Pediatr Neurol (1998) 1.21
Tuberous sclerosis gene 2 product modulates transcription mediated by steroid hormone receptor family members. J Biol Chem (1998) 1.21
Superiority of denaturing high performance liquid chromatography over single-stranded conformation and conformation-sensitive gel electrophoresis for mutation detection in TSC2. Ann Hum Genet (1999) 1.21
Identification of VAV2 on 9q34 and its exclusion as the tuberous sclerosis gene TSC1. Ann Hum Genet (1995) 1.21
Tuberous sclerosis. Arch Dermatol (1994) 1.20
Pulmonary lymphangioleiomyomatosis in a man. Am J Respir Crit Care Med (2000) 1.20
Cell motility as a prognostic factor in Stage I nonsmall cell lung carcinoma: the role of gelsolin expression. Cancer (1999) 1.18
Mutational analysis of patients with neurofibromatosis 2. Am J Hum Genet (1994) 1.17
The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons. J Neurosci (1997) 1.17
Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers. Ann Neurol (2001) 1.16
The actin-binding proteins adseverin and gelsolin are both highly expressed but differentially localized in kidney and intestine. J Cell Sci (1998) 1.16
TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity. Oncogene (2009) 1.16
Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis. J Med Genet (2000) 1.15
Differential requirement of CAAX-mediated posttranslational processing for Rheb localization and signaling. Oncogene (2009) 1.14
Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemia. Ann Hum Genet (2006) 1.14
Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis. J Clin Invest (1987) 1.14
Cloning and chromosomal localization of the human cytoskeletal alpha-actinin gene reveals linkage to the beta-spectrin gene. Am J Hum Genet (1990) 1.13
A high-resolution linkage map of human 9q34.1. Genomics (1993) 1.13
The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas. Mod Pathol (1999) 1.13
Distinct biochemical characteristics of the two human profilin isoforms. Eur J Biochem (1995) 1.12
Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung. J Clin Oncol (1995) 1.11
Comparisons of CapG and gelsolin-null macrophages: demonstration of a unique role for CapG in receptor-mediated ruffling, phagocytosis, and vesicle rocketing. J Cell Biol (2001) 1.11
Clinical and biochemical manifestations of hyaluronidase deficiency. N Engl J Med (1996) 1.11
Actin-binding protein (ABP-280) filamin gene (FLN) maps telomeric to the color vision locus (R/GCP) and centromeric to G6PD in Xq28. Genomics (1993) 1.10
Human complement factor I: analysis of cDNA-derived primary structure and assignment of its gene to chromosome 4. J Biol Chem (1987) 1.10
Novel mutations detected in the TSC2 gene from both sporadic and familial TSC patients. Hum Mol Genet (1996) 1.09
Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. J Neurosci Res (1992) 1.08
Caspase-3-induced gelsolin fragmentation contributes to actin cytoskeletal collapse, nucleolysis, and apoptosis of vascular smooth muscle cells exposed to proinflammatory cytokines. Eur J Cell Biol (1998) 1.08
Aggressive variants of chromophobe renal cell carcinoma. Cancer (1996) 1.07
Evidence for genetic heterogeneity in tuberous sclerosis: one locus on chromosome 9 and at least one locus elsewhere. Am J Hum Genet (1992) 1.07
Localization of one gene for tuberous sclerosis within 9q32-9q34, and further evidence for heterogeneity. Am J Hum Genet (1991) 1.06
New developments in the neurobiology of the tuberous sclerosis complex. Neurology (1999) 1.04
Grafting genetically modified cells into the rat brain: characteristics of E. coli beta-galactosidase as a reporter gene. Brain Res Mol Brain Res (1989) 1.03
Fine mapping of the nail-patella syndrome locus at 9q34. Am J Hum Genet (1997) 1.03
Gelsolin as a negative prognostic factor and effector of motility in erbB-2-positive epidermal growth factor receptor-positive breast cancers. Clin Cancer Res (2001) 1.03